Get started
Author

Taichi Yabuno

Observed names: Taichi YABUNO, 薮野, 太一
ORCID: 0009-0007-5173-8733
Observed ORCID: 0009-0007-5173-8733
OpenAlex ID: A5068760926
Blood Perfusion Assessment by Indocyanine Green Fluorescence Imaging for Minimally Invasive Rectal Cancer Surgery (EssentiAL trial): A Randomized Clinical Trial
2023 · Jun Watanabe, Ichiro Takemasa, et al. · Annals of Surgery · 189
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial
2024 · Manabu Shiozawa, Yu Sunakawa, et al. · Nature Communications · 23
PDF
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial
2018 · Shigeyoshi Iwamoto, Akira Ooki, et al. · Cancer Medicine · 18
PDF
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
2020 · Akira Ooki, Satoshi Morita, et al. · Cancer Medicine · 13
PDF
A Case of Endometriosis of the Ileum Causing Intestinal Obstruction in Which Mri Was Useful in Preoperative Diagnosis
2004 · Taichi YABUNO, Toru WATANABE, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 11
PDF
Impact of Low Ligation on Bowel Perfusion and Anastomotic Leakage in Minimally Invasive Rectal Cancer Surgery: A Post Hoc Analysis of a Randomized Controlled Trial
2025 · Kei Kimura, Jun Watanabe, et al. · Diseases of the Colon & Rectum · 10
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial
2022 · Akira Ooki, Satoshi Morita, et al. · BMC Cancer · 9
PDF
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
2020 · Akira Ooki, Satoshi Morita, et al. · Cancer Medicine · 9
PDF
Acute iliac arterial thrombosis during laparoscopic abdominoperineal resection
2019 · Kota Sahara, Atsushi Ishibe, et al. · Journal of Surgical Case Reports · 6
PDF
A Case of Appendiceal Bleeding Due to Dieulafoy's Lesion
2011 · Masashi YAHAGI, Masazumi TAKAHASHI, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 5
PDF
A case of neurofibroma of the appendix in von Recklinghausen disease.
2011 · Shinya Sugimoto, Masazumi Takahashi, et al. · PubMed · 5
Safety analysis of the randomized phase II study of FOLFOXIRI plus cetuximab versus FOLFOXIRI plus bevacizumab as the first-line treatment in metastatic colorectal cancer with RAS wild-type tumors: The DEEPER trial (JACCRO CC-13).
2021 · Takanori Watanabe, Akihito Tsuji, et al. · Journal of Clinical Oncology · 4
Adenocarcinoma Arising in Ectopic Pancreas of Meckel’s Diverticulum
2019 · Shizuka Sakurai, Yohei Ota, et al. · 日本消化器外科学会雑誌 · 4
PDF
A Case of Meckel's Diverticulum Torsion
2010 · Jun WATANABE, Taichi YABUNO, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 4
PDF
Modified (m)-FOLFOXIRI plus cetuximab versus m-FOLFOXIRI plus bevacizumab as initial treatment of patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer: Survival analysis of the phase II randomized DEEPER trial by JACCRO.
2023 · Yu Sunakawa, Manabu Shiozawa, et al. · Journal of Clinical Oncology · 3
A Case of Small Bowel Volvulus Accompanied by a Jejunal Divrticulum
2005 · Hideaki KATO, Taichi YABUNO, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 3
PDF
Treatment Outcomes of Laparoscopic Suture Rectopexy for Rectal Prolapse
2025 · Takamichi Kudo, Taichi Yabuno, et al. · Nihon Daicho Komonbyo Gakkai Zasshi · 2
PDF
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with carcinomatous lymphangitis of the lung].
2011 · Yumi Daimon, Masazumi Takahashi, et al. · PubMed · 2
A Case of Jejunocolic Fistula Associated With Sigmoid Colon Cancer
2004 · Masahiko KAWAGUCHI, Taichi YABUNO, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 2
PDF
Final analysis of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13).
2025 · Akihito Tsuji, Yu Sunakawa, et al. · Journal of Clinical Oncology · 1
PDF
The efficacy and safety of FOLFIRI+BEV/mXELIRI+BEV by UGT1A1 polymorphisms in metastatic colorectal cancer AXEPT trial
2019 · Hiroshi Matsuoka, Yoshinori Kagawa, et al. · Annals of Oncology · 1
Progressive Severe Clostridium difficile Infection after Abdominoperineal Resection
2018 · Kota Sahara, Yohei Ohta, et al. · 日本消化器外科学会雑誌 · 1
PDF
A randomized phase II study to investigate the deepness of response (DpR) of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer (mCRC) patients with RAS wild-type tumors: DEEPER.
2017 · Akihito Tsuji, Yu Sunakawa, et al. · Journal of Clinical Oncology · 1
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial
2026 · Yu Sunakawa, Manabu Shiozawa, et al. · Journal of Clinical Oncology
PDF
Robotic versus laparoscopic rectal resection: impact on primary postoperative ileus and the role of intraoperative fluid balance: a propensity score-matched cohort study
2026 · Tetsuhiro Urashima, Taichi Yabuno, et al. · Surgical Endoscopy
Works count: 38
Citation count: 326
H-index: 8
I10-index: 6
Year
Topic
Type